Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

about

Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

Item

http://www.wikidata.org/entity/Q47098698

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@en

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@nl

type

Item

label

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@en

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@nl

prefLabel

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@en

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@nl

P1476

Can Replacing CA125 with HE4 i ...... Assessment of Adnexal Tumors?

@en

P2093

Krzysztof Cendrowski

http://www.w3.org/2001/XMLSchema#string

Robert Piórkowski

http://www.w3.org/2001/XMLSchema#string

Włodzimierz Sawicki

http://www.w3.org/2001/XMLSchema#string

P2860

A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.

Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.

Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.

Modification of cutoff values for HE4, CA125, the Risk of Malignancy Index, and the Risk of Malignancy Algorithm for ovarian cancer detection in Jakarta, Indonesia.

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses.

Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.

Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.

P304

6712376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/6712376

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Paweł Jan Stanirowski

Nabil Abdalla

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29238719

http://www.w3.org/2001/XMLSchema#string

P932

5697390

http://www.w3.org/2001/XMLSchema#string